These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38047720)

  • 21. Edmonton symptom assessment scale: Italian validation in two palliative care settings.
    Moro C; Brunelli C; Miccinesi G; Fallai M; Morino P; Piazza M; Labianca R; Ripamonti C
    Support Care Cancer; 2006 Jan; 14(1):30-7. PubMed ID: 15937688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychometric Properties of the Icelandic Version of the Revised Edmonton Symptom Assessment Scale.
    Gretarsdottir H; Fridriksdottir N; Gunnarsdottir S
    J Pain Symptom Manage; 2016 Jan; 51(1):133-7. PubMed ID: 26384555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gaps in the Management of Depression Symptoms Following Cancer Diagnosis: A Population-Based Analysis of Prospective Patient-Reported Outcomes.
    Hallet J; Davis LE; Isenberg-Grzeda E; Mahar AL; Zhao H; Zuk V; Moody L; Coburn NG
    Oncologist; 2020 Jul; 25(7):e1098-e1108. PubMed ID: 32100906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of early palliative care according to baseline symptom severity: Secondary analysis of a cluster-randomized controlled trial in patients with advanced cancer.
    Rodin R; Swami N; Pope A; Hui D; Hannon B; Le LW; Zimmermann C
    Cancer Med; 2022 Apr; 11(8):1869-1878. PubMed ID: 35142091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of routine Edmonton symptom assessment system use on receiving palliative care services: results of a population-based retrospective-matched cohort analysis.
    Barbera L; Sutradhar R; Earle CC; Howell D; Mittman N; Li Q; Thiruchelvam D; Seow H
    BMJ Support Palliat Care; 2023 Oct; 13(e1):e144-e149. PubMed ID: 32943469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening Performance of Edmonton Symptom Assessment System in Kidney Transplant Recipients.
    Battaglia Y; Zerbinati L; Piazza G; Martino E; Provenzano M; Esposito P; Massarenti S; Andreucci M; Storari A; Grassi L
    J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32252326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stepped approach to improving sexual function after gynaecological cancer: the SAFFRON feasibility RCT.
    Gessler S; King M; Lemma A; Barber J; Jones L; Dunning S; Madden V; Pilling S; Hunter R; Fonagy P; Summerville K; MacDonald N; Olaitan A; Lanceley A
    Health Technol Assess; 2019 Feb; 23(6):1-92. PubMed ID: 30798790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Symptom screening with Targeted Early Palliative care (STEP) versus usual care for patients with advanced cancer: a mixed methods study.
    Zimmermann C; Pope A; Hannon B; Bedard PL; Rodin G; Dhani N; Li M; Herx L; Krzyzanowska MK; Howell D; Knox JJ; Leighl NB; Sridhar S; Oza AM; Lheureux S; Booth CM; Liu G; Castro JA; Swami N; Sue-A-Quan R; Rydall A; Le LW
    Support Care Cancer; 2023 Jun; 31(7):404. PubMed ID: 37341839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Italian version of the Edmonton Symptom Assessment System (ESAS)-Total Care (TC): development and psychometric validation in patients undergoing cancer treatment or follow-up.
    Ripamonti C; Leporati R; De Feo G; Di Pede P; Toffolatti L; Guglielmo M; La Carpia D; Miccinesi G; Chiesi F
    Support Care Cancer; 2022 Mar; 30(3):1923-1933. PubMed ID: 34623487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Support, Education, and Advocacy (SEA) Program of Care for Women With Metastatic Breast Cancer: A Nurse-Led Palliative Care Demonstration Program.
    Reiser V; Rosenzweig M; Welsh A; Ren D; Usher B
    Am J Hosp Palliat Care; 2019 Oct; 36(10):864-870. PubMed ID: 30974954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Minimal Clinically Important Difference in the Physical, Emotional, and Total Symptom Distress Scores of the Edmonton Symptom Assessment System.
    Hui D; Shamieh O; Paiva CE; Khamash O; Perez-Cruz PE; Kwon JH; Muckaden MA; Park M; Arthur J; Bruera E
    J Pain Symptom Manage; 2016 Feb; 51(2):262-9. PubMed ID: 26482223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and pilot testing of a clinic implementation program delivering physical activity electronic referrals to cancer survivors.
    Faro JM; Yue KL; Leach HJ; Crisafio ME; Lemon SC; Wang B; McManus DD; Sadasivam RS
    Transl Behav Med; 2023 Sep; 13(10):794-803. PubMed ID: 37318360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rural Cancer Survivors' Perceptions of a Nurse-Led Telehealth Intervention to Manage Cancer-Related Distress.
    Bernacchi V; LeBaron VT; Hinton ID; DeGuzman PB
    Oncol Nurs Forum; 2023 Feb; 50(2):173-184. PubMed ID: 37677802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Edmonton Symptom Assessment System, a proposed tool for distress screening in cancer patients: development and refinement.
    Watanabe SM; Nekolaichuk CL; Beaumont C
    Psychooncology; 2012 Sep; 21(9):977-85. PubMed ID: 21671304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Edmonton Symptom Assessment System: A narrative review of a standardized symptom assessment tool in head and neck oncology.
    Noel CW; Forner D; Chepeha DB; Baran E; Chan KKW; Parmar A; Husain Z; Karam I; Hallet J; Coburn NG; Eskander A
    Oral Oncol; 2021 Dec; 123():105595. PubMed ID: 34775181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Web-Based Intervention to Reduce Distress After Prostate Cancer Treatment: Development and Feasibility of the Getting Down to Coping Program in Two Different Clinical Settings.
    Cockle-Hearne J; Barnett D; Hicks J; Simpson M; White I; Faithfull S
    JMIR Cancer; 2018 Apr; 4(1):e8. PubMed ID: 29712628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncology Nurses' Attitudes Toward the Edmonton Symptom Assessment System: Results From a Large Cancer Care Ontario Study.
    Green E; Yuen D; Chasen M; Amernic H; Shabestari O; Brundage M; Krzyzanowska MK; Klinger C; Ismail Z; Pereira J
    Oncol Nurs Forum; 2017 Jan; 44(1):116-125. PubMed ID: 27991609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implementing Systematic Screening and Structured Care for Distressed Callers Using Cancer Council's Telephone Services: Protocol for a Randomized Stepped-Wedge Trial.
    Fradgley EA; Boltong A; O'Brien L; Boyes AW; Lane K; Beattie A; Clinton-McHarg T; Jacobsen PB; Doran C; Barker D; Roach D; Taylor J; Paul CL
    JMIR Res Protoc; 2019 May; 8(5):e12473. PubMed ID: 31099341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequency of anxiety and depression and screening performance of the Edmonton Symptom Assessment Scale in a psycho-oncology clinic.
    Valentine A; Brown J; Lacourt T; Chen M; De La Garza R; Bruera E
    Psychooncology; 2022 Feb; 31(2):290-297. PubMed ID: 34546618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.